TrialBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis with Prior Exposure to Janus Kinase 1/2 Inhibitors.

Mohamed Shanavas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.